3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma
Clinical trial NCT01183884 · TERMINATED
Trial details
- NCT number
- NCT01183884
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2018-11-09
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.